Saved in:
Similar Items
Detection of Two High Pathogenicity Avian Influenza Virus (HPAIV) Subtypes, H5N1 and H5N5, in a Mass Mortality Event in Wild Seabirds and Co-Location With Dead Seals.
by: Falchieri, Marco, et al.
Published: (2026)
by: Falchieri, Marco, et al.
Published: (2026)
Genomic analysis of high pathogenicity avian influenza viruses from Antarctica reveals multiple introductions from South America.
by: Ogrzewalska, Maria, et al.
Published: (2026)
by: Ogrzewalska, Maria, et al.
Published: (2026)
Genetic Diversity of Highly Pathogenic Avian Influenza Viruses Isolated in Hokkaido, Japan, During Winter 2024-2025.
by: Isoda, Norikazu, et al.
Published: (2025)
by: Isoda, Norikazu, et al.
Published: (2025)
No evidence of influenza A virus infection in marine mammals stranded in Basque Country coast (Northern Spain) in the context of H5N1 clade 2.3.4.4b expansion.
by: López-Morales, Ane, et al.
Published: (2026)
by: López-Morales, Ane, et al.
Published: (2026)
Highly pathogenic avian influenza virus (H5N5) detected in an Atlantic walrus () in the Svalbard Archipelago, Norway, 2023.
by: Postel, Alexander, et al.
Published: (2025)
by: Postel, Alexander, et al.
Published: (2025)
Interesting post-mortem findings in a H1N1 influenza-positive pneumonia patient
by: Kolady Vijayakumar Vinu Balraam
Published: (2019)
by: Kolady Vijayakumar Vinu Balraam
Published: (2019)
Host-specific functional evolution of seal influenza A virus NS1 protein following avian-to-seal transmission.
by: Kuryshko, Maryna, et al.
Published: (2026)
by: Kuryshko, Maryna, et al.
Published: (2026)
H5N1 Wastewater Detection Demo Dataset
by: Farookhi, Heba
Published: (2025)
by: Farookhi, Heba
Published: (2025)
Influenza vaccination in Brazil: rationale and caveats
by: Sérgio Souza da Cunha
Published: (2005)
by: Sérgio Souza da Cunha
Published: (2005)
In Vitro and In Silico Studies on the Anti-H1N1 Activity of Bioactive Compounds from Marine-Derived .
by: Chen, Yung-Husan, et al.
Published: (2025)
by: Chen, Yung-Husan, et al.
Published: (2025)
Relação entre morbidade hospitalar e cobertura vacinal contra Influenza A
by: Fernanda Ribeiro Baptista Marques
Published: (2012)
by: Fernanda Ribeiro Baptista Marques
Published: (2012)
Impact of First SARS‐CoV‐2 Infection Variant on Serological Responses Against Omicron: Findings From the SIREN Study
by: Ferdinando Insalata, et al.
Published: (2026)
by: Ferdinando Insalata, et al.
Published: (2026)
Antigenic Characterization of H1N1 Influenza Viruses That Circulated During the 2019–2020 Season in Philadelphia, Pennsylvania
by: Lydia M. Mendoza, et al.
Published: (2025)
by: Lydia M. Mendoza, et al.
Published: (2025)
Influenza. Vacunas clásicas y novedosas a las puertas de otra pandemia
by: Raiza Martínez
Published: (2006)
by: Raiza Martínez
Published: (2006)
Prevalencia de síntomas parecidos a los de influenza en una ciudad del noreste de México.
by: Jesús Santos-Guzmán
Published: (2011)
by: Jesús Santos-Guzmán
Published: (2011)
Consideraciones para la vacunación en caso de una pandemia de influenza
by: Alba María Ropero Álvarez
Published: (2005)
by: Alba María Ropero Álvarez
Published: (2005)
Evaluating Bacillus Calmette–Guérin Polysaccharide Nucleic Acid as an Adjuvant for Influenza Vaccines in Mice
by: Sijing Yan, et al.
Published: (2025)
by: Sijing Yan, et al.
Published: (2025)
Effectiveness of the XBB.1.5 COVID‐19 Vaccines Against SARS‐CoV‐2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024
by: Liliana Antunes, et al.
Published: (2025)
by: Liliana Antunes, et al.
Published: (2025)
Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in Older Adults During the JN.1 Lineage‐Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024
by: Lore Merdrignac, et al.
Published: (2024)
by: Lore Merdrignac, et al.
Published: (2024)
Neurologic Complications of Influenza and Potential Protective Vaccine Effects
by: Ann R. Falsey
Published: (2025)
by: Ann R. Falsey
Published: (2025)
Age‐Related Asymptomatic Rhinovirus Infections Contribute to the Sustained Prevalence in Adults and Are Not Mitigated by Nonpharmaceutical Interventions
by: Dong Wei, et al.
Published: (2026)
by: Dong Wei, et al.
Published: (2026)
Expanded Genomic Surveillance and Seasonal Comparisons of Human Respiratory Syncytial Virus Infections in Minnesota, USA, 2023–2025
by: Daniel Evans, et al.
Published: (2026)
by: Daniel Evans, et al.
Published: (2026)
High Infection Risk Among Health Care Workers During the First SARS‐CoV‐2 Wave in Niamey, Niger
by: Hamidou Lazoumar Ramatoulaye, et al.
Published: (2025)
by: Hamidou Lazoumar Ramatoulaye, et al.
Published: (2025)
Cardiac Characteristics of Hospitalized Influenza Patients: An Interim Analysis From the FluHeart Study
by: Kristoffer Grundtvig Skaarup, et al.
Published: (2025)
by: Kristoffer Grundtvig Skaarup, et al.
Published: (2025)
Incidence of Hospitalization due to Influenza‐Associated Severe Acute Respiratory Infection During 2010–2019 in Bangladesh
by: Mohammad Abdul Aleem, et al.
Published: (2024)
by: Mohammad Abdul Aleem, et al.
Published: (2024)
Changes in the Epidemiology of Influenza and Respiratory Syncytial Virus During 2020–2022 Relative to the Pre‐COVID‐19 Pandemic Period (2017–2020) From Systematic Sentinel Syndromic Surveillance in South Africa
by: Sibongile Walaza, et al.
Published: (2026)
by: Sibongile Walaza, et al.
Published: (2026)
Longitudinal SARS‐CoV‐2 Antibody Response in Healthcare Workers: Benefit of Prior Infection and Heterologous Boosting on Anti‐Spike IgG Immunity
by: Els Van Nedervelde, et al.
Published: (2026)
by: Els Van Nedervelde, et al.
Published: (2026)
Issue Information
Published: (2025)
Published: (2025)
Influenza Epidemiology in Finland During and After the COVID‐19 Pandemic: Surveillance Data Analysis (2019–2024)
by: Ulrike Baum, et al.
Published: (2025)
by: Ulrike Baum, et al.
Published: (2025)
Burden of Severe Disease Associated With Influenza, SARS‐CoV‐2 and RSV in Spain During the 2024–2025 Winter Season
by: Daniel Aguilar Figueroa, et al.
Published: (2025)
by: Daniel Aguilar Figueroa, et al.
Published: (2025)
Adverse Effects Related to Paediatric Influenza Vaccination and Its Influence on Vaccination Acceptability. The FLUTETRA Study: A Survey Conducted in the Region of Murcia, Spain
by: Matilde Zornoza Moreno, et al.
Published: (2024)
by: Matilde Zornoza Moreno, et al.
Published: (2024)
Correction to “The Development of Global Genomic Surveillance of Respiratory Syncytial Virus: Insights From 25 Project Countries, 2019–2023”
Published: (2026)
Published: (2026)
The Second Round of a Population‐Based Seroprevalence Study of Anti–SARS‐CoV‐2 Antibodies and COVID‐19 Vaccination Assessment in the Republika Srpska, Bosnia and Herzegovina
by: Jela Aćimović, et al.
Published: (2025)
by: Jela Aćimović, et al.
Published: (2025)
SARS‐CoV‐2 Viral Load and Cytokine Dynamics Profile as Early Signatures of Long COVID Condition in Hospitalized Individuals
by: Jacobo Alonso Domínguez, et al.
Published: (2025)
by: Jacobo Alonso Domínguez, et al.
Published: (2025)
Measures of Population Immunity Can Predict the Dominant Clade of Influenza A (H3N2) in the 2017–2018 Season and Reveal Age‐Associated Differences in Susceptibility and Antibody‐Binding Specificity
by: Kangchon Kim, et al.
Published: (2024)
by: Kangchon Kim, et al.
Published: (2024)
Should We Vaccinate Healthcare Workers Against Respiratory Syncytial Virus?
by: Klinger Soares Faico‐Filho, et al.
Published: (2024)
by: Klinger Soares Faico‐Filho, et al.
Published: (2024)
Molecular Analysis of Human Respiratory Syncytial Virus Group B Strains Isolated in Kenya Before and During the Emergence of Pandemic Influenza A/H1N1
by: Julia Wangui, et al.
Published: (2025)
by: Julia Wangui, et al.
Published: (2025)
Evaluating COVID‐19 Transmission in a Series of Cases and Contacts in Three Municipalities of Colombia: Insights From the WHO First Few X Protocol, August 2020–January 2021
by: Damaris Heredia, et al.
Published: (2026)
by: Damaris Heredia, et al.
Published: (2026)
Changing Epidemiological Pattern and Higher Disease Burden of Influenza in China, 2022 to 2025
by: Hairu Yu, et al.
Published: (2025)
by: Hairu Yu, et al.
Published: (2025)
An Overview of the H5N1 mRNA Vaccine Pipeline
by: Daniele Focosi, et al.
Published: (2025)
by: Daniele Focosi, et al.
Published: (2025)
Similar Items
-
Detection of Two High Pathogenicity Avian Influenza Virus (HPAIV) Subtypes, H5N1 and H5N5, in a Mass Mortality Event in Wild Seabirds and Co-Location With Dead Seals.
by: Falchieri, Marco, et al.
Published: (2026) -
Genomic analysis of high pathogenicity avian influenza viruses from Antarctica reveals multiple introductions from South America.
by: Ogrzewalska, Maria, et al.
Published: (2026) -
Genetic Diversity of Highly Pathogenic Avian Influenza Viruses Isolated in Hokkaido, Japan, During Winter 2024-2025.
by: Isoda, Norikazu, et al.
Published: (2025) -
No evidence of influenza A virus infection in marine mammals stranded in Basque Country coast (Northern Spain) in the context of H5N1 clade 2.3.4.4b expansion.
by: López-Morales, Ane, et al.
Published: (2026) -
Highly pathogenic avian influenza virus (H5N5) detected in an Atlantic walrus () in the Svalbard Archipelago, Norway, 2023.
by: Postel, Alexander, et al.
Published: (2025)